WO2007046083A3 - Compositions for treatment of eye diseases - Google Patents
Compositions for treatment of eye diseases Download PDFInfo
- Publication number
- WO2007046083A3 WO2007046083A3 PCT/IL2006/001168 IL2006001168W WO2007046083A3 WO 2007046083 A3 WO2007046083 A3 WO 2007046083A3 IL 2006001168 W IL2006001168 W IL 2006001168W WO 2007046083 A3 WO2007046083 A3 WO 2007046083A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compositions
- eye diseases
- treatment
- present
- eye
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2008004981A MX2008004981A (en) | 2005-10-16 | 2006-10-05 | Compositions for treatment of eye diseases. |
AU2006305546A AU2006305546A1 (en) | 2005-10-16 | 2006-10-05 | Compositions for treatment of eye diseases |
JP2008535182A JP2009515821A (en) | 2005-10-16 | 2006-10-05 | Composition for treating eye diseases |
EP06796159A EP1937240A2 (en) | 2005-10-16 | 2006-10-05 | Compositions for treatment of eye diseases |
IL190779A IL190779A0 (en) | 2005-10-16 | 2008-04-10 | Compositions for treatment of eye diseases |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL171452 | 2005-10-16 | ||
IL17145205 | 2005-10-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007046083A2 WO2007046083A2 (en) | 2007-04-26 |
WO2007046083A3 true WO2007046083A3 (en) | 2011-05-19 |
Family
ID=37962894
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2006/001168 WO2007046083A2 (en) | 2005-10-16 | 2006-10-05 | Compositions for treatment of eye diseases |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1937240A2 (en) |
JP (1) | JP2009515821A (en) |
AU (1) | AU2006305546A1 (en) |
IL (1) | IL190779A0 (en) |
MX (1) | MX2008004981A (en) |
RU (1) | RU2008119234A (en) |
WO (1) | WO2007046083A2 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5411431B2 (en) | 2004-11-09 | 2014-02-12 | カプロン インコーポレイテッド | Methods and materials for skin care |
US8022246B2 (en) * | 2006-10-10 | 2011-09-20 | The Burnham Institute For Medical Research | Neuroprotective compositions and methods |
DE202007012373U1 (en) * | 2007-09-04 | 2009-01-08 | Omnivision Gmbh | Dietary supplements, sachets containing a dietary supplement and use of a dietary supplement |
CA2741746C (en) * | 2008-11-03 | 2016-08-23 | Giuliani S.P.A. | Therapeutic, dietary or cosmetic use of compounds with specific anti-apoptotic activity toward caspase-3, and compositions containing these compounds |
CN105193777B (en) * | 2009-01-19 | 2019-06-28 | 利科雷德有限公司 | The synergistic combination of carotenoid and polyphenol |
WO2011076869A1 (en) * | 2009-12-22 | 2011-06-30 | Aakerlund Hans-Erik | Isolated green plant material |
JP2011256118A (en) * | 2010-06-07 | 2011-12-22 | Kao Corp | Il-8 and gm-csf expression inhibitor |
JP2013540766A (en) * | 2010-10-04 | 2013-11-07 | カプロン インコーポレイテッド | Cosmetic skin care composition |
ES2754279T3 (en) * | 2011-07-13 | 2020-04-16 | Univ Georgia | Use of xanthophyll carotenoids to improve visual performance and neuronal efficiency |
CN103798808A (en) * | 2012-11-15 | 2014-05-21 | 中国科学院大连化学物理研究所 | Nutrient formula and application thereof to food or medicine for reliving asthenopia |
EA035620B1 (en) | 2014-08-11 | 2020-07-16 | Борд Оф Сьюпервайзорз Оф Луизиана Стэйт Юниверсити Энд Эгрикалчурал Энд Мекэникал Колледж | Methods and composition for treating or preventing cataract |
CN107106625A (en) * | 2014-11-25 | 2017-08-29 | 利库德有限公司 | The biological activity tomato compositions of lycopene with decrement |
JP7105532B2 (en) * | 2017-05-10 | 2022-07-25 | ロート製薬株式会社 | Composition for prevention, improvement or treatment of posterior segment disease |
WO2019021299A1 (en) * | 2017-07-25 | 2019-01-31 | Tathagata Dutta | A topical ocular suspension of antioxidants |
WO2019087189A1 (en) * | 2017-11-01 | 2019-05-09 | Lycored Ltd. | A method for improving ocular blood flow |
US11696593B2 (en) | 2018-08-24 | 2023-07-11 | Bioscience Formulators, LLC | Astaxanthin nutritional compositions and uses |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6103756A (en) * | 1999-08-11 | 2000-08-15 | Vitacost Inc. | Ocular orally ingested composition for prevention and treatment of individuals |
US6573299B1 (en) * | 1999-09-20 | 2003-06-03 | Advanced Medical Instruments | Method and compositions for treatment of the aging eye |
-
2006
- 2006-10-05 MX MX2008004981A patent/MX2008004981A/en not_active Application Discontinuation
- 2006-10-05 EP EP06796159A patent/EP1937240A2/en not_active Withdrawn
- 2006-10-05 WO PCT/IL2006/001168 patent/WO2007046083A2/en active Application Filing
- 2006-10-05 RU RU2008119234/15A patent/RU2008119234A/en not_active Application Discontinuation
- 2006-10-05 JP JP2008535182A patent/JP2009515821A/en active Pending
- 2006-10-05 AU AU2006305546A patent/AU2006305546A1/en not_active Abandoned
-
2008
- 2008-04-10 IL IL190779A patent/IL190779A0/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6103756A (en) * | 1999-08-11 | 2000-08-15 | Vitacost Inc. | Ocular orally ingested composition for prevention and treatment of individuals |
US6573299B1 (en) * | 1999-09-20 | 2003-06-03 | Advanced Medical Instruments | Method and compositions for treatment of the aging eye |
Also Published As
Publication number | Publication date |
---|---|
AU2006305546A1 (en) | 2007-04-26 |
MX2008004981A (en) | 2008-10-17 |
WO2007046083A2 (en) | 2007-04-26 |
JP2009515821A (en) | 2009-04-16 |
RU2008119234A (en) | 2009-11-27 |
EP1937240A2 (en) | 2008-07-02 |
IL190779A0 (en) | 2009-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007046083A3 (en) | Compositions for treatment of eye diseases | |
EP2514423A3 (en) | Method of treatment of age-related macular degeneration (AMD) | |
WO2006071548A3 (en) | Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases | |
MX2007008848A (en) | Methods and compositions for the treatment of ocular disorders. | |
MX354184B (en) | Alkoxy compounds for disease treatment. | |
WO2007076360A8 (en) | (indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)- pyrazines for treating rho kinase-mediated diseases and conditions | |
WO2010048332A3 (en) | Compounds for treating ophthalmic diseases and disorders | |
WO2007044668A3 (en) | Compstatin and analogs thereof for eye disorders | |
WO2006096439A3 (en) | Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases | |
PH12015501207A1 (en) | Amine derivative compounds for treating ophthalmic diseases and disorders | |
WO2009055006A8 (en) | Deuterated darunavir | |
WO2006073786A3 (en) | Ophthalmic compositions comprising steroid and cyclosporine for dry eye therapy | |
WO2009005794A3 (en) | Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders | |
WO2008013986A3 (en) | Compositions and methods for treating or preventing ophthalmic light toxicity | |
WO2007098122A3 (en) | Methods for the treatment of macular degeneration and related eye conditions | |
WO2010028088A3 (en) | Sulfur-linked compounds for treating opthalmic diseases and disorders | |
WO2008020032A8 (en) | Use of 2,5-dihydroxybenzene derivatives for the treatment of ocular diseases | |
MX2019008963A (en) | Composition containing ursodeoxycholic acid for prevention or treatment of visual impairment. | |
WO2007096886A3 (en) | Composition and methods for treating and preventing age-related macular degeneration | |
WO2007089673A8 (en) | Compositions and methods for treatment of ophthalmic diseases and disorders | |
WO2004016214A3 (en) | Methods and compositions for treatment of macular and retinal disease | |
WO2011137344A3 (en) | Anti-s1p antibody treatment of patients with ocular disease | |
WO2008048675A3 (en) | Treatment for age-related macular degeneration and other diseases of the eye | |
WO2008152507A3 (en) | Compositions and methods for treating ophthalmic disorders | |
WO2008136034A3 (en) | Ophthalmic compositions for the treatment of ocular hypertension and glaucoma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 190779 Country of ref document: IL Ref document number: 2006305546 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006796159 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008535182 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/a/2008/004981 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWP | Wipo information: published in national office |
Ref document number: 2006305546 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008119234 Country of ref document: RU |
|
WWP | Wipo information: published in national office |
Ref document number: 2006796159 Country of ref document: EP |
|
ENPW | Started to enter national phase and was withdrawn or failed for other reasons |
Ref document number: PI0617420 Country of ref document: BR Free format text: PEDIDO RETIRADO, UMA VEZ QUE, SEGUNDO O ART. 216 INCISO 2O DA LPI, O DOCUMENTO DE PROCURACAO NAO FOI PROTOCOLADO EM SESSENTA DIAS CONTADOS DA PRATICA DO PRIMEIRO ATO DA PARTE NO PROCESSO, E NAO HOUVE MANIFESTACAO DO REQUERENTE FRENTE A PUBLICACAO DO ARQUIVAMENTO DA PETICAO (11.6.1) NA RPI 2150 DE 20/03/2012. |